Second International Electronic Conference on Medicinal Chemistry (ECMC-2)
1
Haute Ecole Provinciale de Hainaut Condorcet, 7330 Saint-Ghislain, Belgium
2
Department of Organic Chemistry, University of Mons-UMONS, 7000 Mons, Belgium
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2017, 10(1), 20; https://doi.org/10.3390/ph10010020
Received: 16 January 2017
/
Accepted: 24 January 2017
/
Published: 31 January 2017
(This article belongs to the Special Issue Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry)
The second International Electronic Conference on Medicinal Chemistry, organized and sponsored by the publisher MDPI AG and the Journal Pharmaceuticals, took place in November 2016 on the SciForum website (www.sciforum.net/conference/ecmc-12). More than 150 authors from 22 countries participated in the event. Selected works presented during the scientific meeting are disclosed in this report.
View Full-Text
Keywords:
biological and therapeutic targets; biomolecules; drug development; drug discovery; medicinal chemistry; pharmacological evaluation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Mayence, A.; Vanden Eynde, J.J. Second International Electronic Conference on Medicinal Chemistry (ECMC-2). Pharmaceuticals 2017, 10, 20. https://doi.org/10.3390/ph10010020
AMA Style
Mayence A, Vanden Eynde JJ. Second International Electronic Conference on Medicinal Chemistry (ECMC-2). Pharmaceuticals. 2017; 10(1):20. https://doi.org/10.3390/ph10010020
Chicago/Turabian StyleMayence, Annie, and Jean Jacques Vanden Eynde. 2017. "Second International Electronic Conference on Medicinal Chemistry (ECMC-2)" Pharmaceuticals 10, no. 1: 20. https://doi.org/10.3390/ph10010020
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
